Make a donation

Pediatric Oncology

Thoracic and vascular surgery

Dermatology, allergology and vascular medicine

Onco-neurology

Onco-neurology Pitié-Salpêtrière Hospital +33 (0)1 42 16 06 43

Oncogeriatrics

Medical Onco-Radiation Therapy

Pneumology

Pneumology Pitié-Salpêtrière Hospital +33 (0)1 42 16 78 84

Urology

Urology Pitié-Salpêtrière Hospital +33 (0)1 42 17 71 50
Contact us

New regimen for the management of cardiotoxicity induced by certain immunotherapies

At the University Institute of Cancerology AP-HP Sorbonne University, teams from the pharmacology and internal medicine departments of the GHU AP-HP Sorbonne University, Inserm and Sorbonne University, coordinated by Prof. Joe-Elie Salem and Prof. Yves Allenbach, have developed a new treatment regimen to reduce mortality in patients suffering from cardiotoxicity due to certain immunotherapies widely used in the treatment of many cancers.

This study was published on February 23, 2023 in
Cancer Discovery
a journal of the American Association for Cancer Research (AACR).